Related Experiment Videos

The effect of VIP on guinea pig taenia coli requires the whole sequence

Peptides
|March 1, 1984
PubMed

Insights

Truncated versions of vasoactive intestinal peptide (VIP) were synthesized and tested for biological activity. These modified peptides, including VIP1-6 and VIP15-28, showed no significant effects, indicating the importance of the full VIP1-28 sequence.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Peptide Chemistry

Background:

  • Vasoactive intestinal peptide (VIP) is a peptide hormone with diverse physiological roles.
  • Understanding the structure-activity relationship of VIP is crucial for its therapeutic applications.
  • Previous studies suggest specific regions of VIP are essential for its activity.

Purpose of the Study:

  • To investigate the biological activity of truncated and modified VIP peptides.
  • To determine the minimal sequence required for VIP's activity on guinea-pig taenia coli.
  • To elucidate the structure-activity relationship of VIP.

Main Methods:

  • Synthesis of truncated VIP peptides (VIP1-6, VIP15-28, VIP18-28).
  • Synthesis of chimeric VIP peptides by joining fragments.
  • Synthesis of Gly17,18,19-VIP mutant.
  • Testing biological activity on isolated guinea-pig taenia coli.

Main Results:

  • Truncated VIP peptides (VIP1-6, VIP15-28, VIP18-28) exhibited no biological activity alone or in combination.
  • Chimeric VIP peptides with omitted mid-portions also lacked detectable biological activity.
  • Gly17,18,19-VIP showed significantly reduced bioactivity compared to native VIP1-28.

Conclusions:

  • The full sequence of VIP1-28 is essential for its biological activity on guinea-pig taenia coli.
  • Modifications or truncations of the VIP sequence abolish or greatly reduce its bioactivity.
  • Specific regions within the VIP sequence are critical for maintaining its physiological function.

Related Concept Videos